{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:16:11Z","timestamp":1761059771061},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1097\/spc.0000000000000075","type":"journal-article","created":{"date-parts":[[2014,7,16]],"date-time":"2014-07-16T09:08:44Z","timestamp":1405501724000},"page":"241-249","source":"Crossref","is-referenced-by-count":5,"title":["Managing advanced penile cancer in 2014"],"prefix":"10.1097","volume":"8","author":[{"given":"Normand","family":"Blais","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elie","family":"Kassouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20211004","doi-asserted-by":"crossref","first-page":"E797","DOI":"10.5489\/cuaj.1794","article-title":"Management of carcinoma of the penis: consensus statement from the Canadian Association of Genitourinary Medical Oncologists (CAGMO).","volume":"7","author":"Richter","year":"2013","journal-title":"Can Urol Assoc J"},{"key":"R5-11-20211004","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijrobp.2013.08.013","article-title":"Stage presentation, care patterns, and treatment outcomes for squamous cell carcinoma of the penis.","volume":"88","author":"Burt","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R6-11-20211004","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.ejca.2012.10.029","article-title":"Population-based survival of penile cancer patients in Europe and the United States of America: no improvement since 1990.","volume":"49","author":"Verhoeven","year":"2013","journal-title":"Eur J Cancer"},{"key":"R10-11-20211004","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.brachy.2013.01.167","article-title":"American Brachytherapy Society-Groupe Europeen de Curietherapie-European Society of Therapeutic Radiation Oncology (ABS-GEC-ESTRO) consensus statement for penile brachytherapy.","volume":"12","author":"Crook","year":"2013","journal-title":"Brachytherapy"},{"key":"R11-11-20211004","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/1097-0142(197702)39:2<456::AID-CNCR2820390214>3.0.CO;2-I","article-title":"An approach for the treatment of penile carcinoma.","volume":"39","author":"Cabanas","year":"1977","journal-title":"Cancer"},{"key":"R12-11-20211004","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.eururo.2013.11.014","article-title":"A hybrid radioactive and fluorescent tracer for sentinel node biopsy in penile carcinoma as a potential replacement for blue dye.","volume":"65","author":"Brouwer","year":"2014","journal-title":"Eur Urol"},{"key":"R14-11-20211004","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/j.1464-410X.2012.11729.x","article-title":"Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma.","volume":"111","author":"Matin","year":"2013","journal-title":"BJU Int"},{"key":"R16-11-20211004","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jso.20414","article-title":"Prognostic factors in node-positive carcinoma of the penis.","volume":"93","author":"Pandey","year":"2006","journal-title":"J Surg Oncol"},{"key":"R17-11-20211004","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","article-title":"Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study.","volume":"28","author":"Pagliaro","year":"2010","journal-title":"J Clin Oncol"},{"key":"R18-11-20211004","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1464-410X.1994.tb09199.x","article-title":"Role of radiation therapy in the treatment of carcinoma of the penis.","volume":"74","author":"Ravi","year":"1994","journal-title":"Br J Urol"},{"key":"R22-11-20211004","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1200\/JCO.2011.34.8367","article-title":"Proof of activity of antiepidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis.","volume":"29","author":"Necchi","year":"2011","journal-title":"J Clin Oncol"},{"key":"R24-11-20211004","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.eururo.2011.02.009","article-title":"Patients experiences of penile cancer.","volume":"59","author":"Branney","year":"2011","journal-title":"Eur Urol"},{"key":"R26-11-20211004","first-page":"A4655","article-title":"Patient perspectives on quality of life after penile cancer.","volume":"60","author":"Mortensen","year":"2013","journal-title":"Dan Med J"}],"container-title":["Current Opinion in Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01263393-201409000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T11:07:51Z","timestamp":1633518471000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01263393-201409000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0000000000000075","relation":{},"ISSN":["1751-4258"],"issn-type":[{"value":"1751-4258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}